EXPLAINED: 6 - The Real Truth

Players Punched, Fans Rioting: The Unthinkable Chaos at Sir Jim Ratcliffe’s OGC Nice

Things have taken a sharp, dramatic turn to plunge the club into crisis.

Sports Illustrated · Dec 2, 2025

Nice players placed on sick leave after ultras confront team at training ground

The Nice players Terem Moffi and Jérémie Boga have been placed on sick leave after the team were confronted by supporters upon their return from a 3-1 defeat at Lorient

The Guardian - UK · Dec 2, 2025

Senegal World Cup 2026 squad: Pape Thiaw's side to take on France

The Senegal World Cup 2026 squad is here, as the Lions of Teranga head into this competition as dark horses

FourFourTwo · Dec 2, 2025

Cancer treatment that allows patients to avoid surgery given approval for NHS use

IN FULL

The Independent UK · Dec 2, 2025

The Fastest Tariff U-Turn in History: How Britain Made Trump Blink on Pharmaceuticals

Fastest tariff reversal ever: Britain wins zero-tariff pharma deal as Trump backs down—NHS faces 25% higher drug costs. See effects on patients and jobs.

International Business Times UK · Dec 2, 2025

New cancer treatment could prevent patients needing ‘devastating’ surgery

The treatment, known as Papillon, could allow patients with rectal cancer to avoid the need for a stoma

The Independent UK · Dec 2, 2025

Ghana World Cup 2026 squad: Carlos Queiroz's final 26-man selection

The Ghana World Cup 2026 squad has been named but a change in the dugout disrupted preparations

FourFourTwo · Dec 1, 2025

The new asthma treatment that could ‘transform lives’

The injection is recommended as an additional maintenance treatment for patients over 12 when usual medications have not proven effective enough

The Independent UK · Nov 26, 2025

Why Is Autolus Therapeutics Stock Trading Higher On Tuesday?

The U.K.’s National Institute for Health and Care Excellence (NICE) published on Tuesday draft guidance recommending Autolus Therapeutics plc’s (NASDAQ:AUTL) Aucatzyl (obecabtagene autoleucel, or obe-cel) for use in the National Health Service (NHS) for adult patients (≥26 years) with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (r/r B-ALL).

Benzinga · Nov 25, 2025

‘Next generation’ treatment to cure leukaemia given NHS approval

‘The biggest thing it offers is hope,’ says patient involved in clinical trial which cured cancer in significant portion of leukaemia sufferers

The Independent UK · Nov 25, 2025